Phase 2/3 Study of ALK-001 in Geographic Atrophy

Clinical trial NCT03845582 · COMPLETED

Trial details

NCT number: NCT03845582
Sponsor: Alkeus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Geographic Atrophy Age Related Macular Degeneration AMD Atrophy, Geographic

Start date: 2019-05-07
Primary completion: 2023-07-25
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.